Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Deccan Digoxin

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Digoxin

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    DSSTox_CID_2934

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Digitalis Shows Promise In Reducing Heart Failure Events
    Digitalis Shows Promise In Reducing Heart Failure Events

    10 May 2026

    // ESCARDIO

    https://www.escardio.org/news/press/press-releases/new-positive-data-on-old-drugs-digitalis-reduces-heart-failure-events/

    ESCARDIO
    10 May 2026
    Share Share
    Health Canada Issues Recalls of Jamp Pharma's Digoxin
    Health Canada Issues Recalls of Jamp Pharma's Digoxin

    03 Jun 2024

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/jamp-digoxin-tablet-over-sized-tablet

    HEALTH CANADA
    03 Jun 2024
    Share Share
    Enforcement Report - Week of April 24, 2024
    Enforcement Report - Week of April 24, 2024

    24 Apr 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-24-2024-1488.pdf

    FDA
    24 Apr 2024
    Share Share
    Enforcement Report - Week of March 27, 2024
    Enforcement Report - Week of March 27, 2024

    27 Mar 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-27-2024-11790.pdf

    FDA
    27 Mar 2024
    Share Share
    Enforcement Report - Week of September 13, 2023
    Enforcement Report - Week of September 13, 2023

    13 Sep 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-13-2023-60327.pdf

    FDA
    13 Sep 2023
    Share Share
    Marlex Pharma Issues Voluntary Nationwide Recall of Digoxin Tablets USP,
    Marlex Pharma Issues Voluntary Nationwide Recall of Digoxin Tablets USP,

    31 Aug 2023

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/marlex-pharmaceuticals-inc-issues-voluntary-nationwide-recall-digoxin-tablets-usp-0125mg-and-digoxin

    FDA
    31 Aug 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.